Alexander O. Schuth
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Denali Therapeutics Inc. (DNLI)
Proxy statement
Current -
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Denali Therapeutics Inc. (DNLI) | Chief Operating and Financial Officer and Secretary | $552,000 | $4,258,045 |
| 2024 | Denali Therapeutics Inc. (DNLI) | Chief Operating and Financial Officer and Secretary | $535,600 | $4,022,759 |
| 2023 | Denali Therapeutics Inc. (DNLI) | Chief Operating and Financial Officer and Secretary | $520,000 | $4,169,183 |
| 2022 | Denali Therapeutics Inc. (DNLI) | Chief Operating and Financial Officer and Secretary | $500,000 | $5,692,052 |
| 2021 | Denali Therapeutics Inc. (DNLI) | Chief Operating and Financial Officer and Secretary | $465,129 | $6,530,026 |
| 2020 | Denali Therapeutics Inc. (DNLI) | Chief Operating and Financial Officer and Secretary | $449,400 | $4,203,402 |
| 2019 | Denali Therapeutics Inc. (DNLI) | Chief Operating Officer and Secretary | $428,000 | $2,476,628 |
| 2018 | Denali Therapeutics Inc. (DNLI) | Chief Operating Officer and Secretary | $400,000 | $3,901,789 |
| 2017 | Denali Therapeutics Inc. (DNLI) | Chief Operating Officer and Secretary | $369,008 | $1,076,937 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.